Company / Financials
ACCENDRA HEALTH INC/VA/ Financials
FY2010-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$2.8B
FY2025 · +3.1% YoY
Net Income
-$1.1B
FY2025 · -203.5% YoY
Profit Margin
-39.9%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$2.5B
FY2025
Total Debt
-
FY2025
Equity
-$461.0M
FY2025
ROA
-44.9%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$2.8B+3.1% YoYNet Income HistoryProfit after all expenses and taxes-$1.1B-203.5% YoYGross Profit HistoryRevenue minus cost of goods sold-Cost of Revenue HistoryDirect costs of producing goods and services sold$1.5B+5.2% YoYOperating Income HistoryProfit from core business operations before interest and taxes$27.5M+112.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$1.1B-1.4% YoYR&D Expense HistoryResearch and development spending-Interest Expense HistoryCost of borrowing and debt obligations$107.2M-0.4% YoYIncome Tax HistoryTotal income tax expense$729.0K-96.5% YoYEPS (Basic) HistoryBasic earnings per share-$0.54-280.0% YoY